Day: November 26, 2025

Nasdaq OMX Copenhagen A/S Charlottenlund, November 26, 2025 Announcement no. 284 Updated financial calendar 2025 and 2026 The date for the publication of the Interim Report for the period January 1 to September 30, 2025 has been changed from today, November 26, 2025, to November 28, 2025. The change is due to the fact that the company is awaiting clarification of matters to be communicated simultaneously with the Interim Report.November 28, 2025 Interim report for the period January 1 to September 30, 2025November 28, 2025 Holding of the extraordinary general meetingMarch 23, 2026 Deadline for submission of proposals for voting at the company’s annual general meetingMarch 31, 2026 Annual Report 2025March 31, 2026 Expected date for convening the annual general meeting.April 30, 2026 Holding of the annual general...

Oslo, 26 November 2025: Vow ASA (ticker OSE: VOW) and its subsidiary Scanship have received a purchase order from a major European shipyard of EUR 13.8 million. Equipment deliveries will start in July 2026 for the first vessel and continue throughout 2028. This order, which is a continuation of series of vessels with existing platforms and two vessel deliveries expected per year, will have its first vessel in operation at the end of 2028. Deliveries of equipment to four firm vessels are agreed. Under the agreement, the customer retains an option to order similar equipment for another six vessels at a later stage with equipment deliveries stretching to 2032. The six options have a total value of EUR 22 million. “Through this contract, we continue our long-standing cooperation with the shipyard and the cruise line. The vessels will be fully...

The Magnum Ice Cream Company (TMICC), the world’s largest ice cream company, today announced the successful completion of a €3 billion debut bond issuance by Magnum ICC Finance B.V., across four tranches. Commenting on the successful issuance, Abhijit Bhattacharya, CFO, The Magnum Ice Cream Company noted “Issuing our inaugural public bond is an important milestone for The Magnum Ice Cream Company as we embark on our journey as a standalone ice cream company. The level of interest shown by the market was fantastic, with the order book being oversubscribed by over seven times. This clearly indicates that our strategy and story as the world’s leading ice cream company resonates with investors.” The debut issuance was completed under the newly established €8 billion Euro Medium Term Note programme of Magnum ICC Finance B.V. guaranteed by The...

NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced the Company’s participation in the 8th Annual Evercore Healthcare Conference taking place in Florida on December 2, 2025, as well as the Piper Sandler Annual Healthcare Conference in New York on December 3, 2025. Mai-Britt Zocca, PhD, President & CEO, and Amy Sullivan, CFO, will participate in a fireside chat and host one-on-one meetings with investors at each conference. Event: 8th Annual Evercore Healthcare ConferenceLocation: Coral Gables, FloridaFireside chat: Tuesday, December 2, 2025, at 7:55 am ETParticipants: Mai-Britt Zocca, PhD, President & CEO, and Amy Sullivan, CFOWebcast Link: https://wsw.com/webcast/evercore52/iobt/2362844 Event:...

TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) — Currency Exchange International, Corp. (“Currency Exchange” or the “Company”) (TSX:CXI) (OTCQX:CURN) announced today a correction to its news release issued earlier today entitled “Currency Exchange International, Corp. Announces Renewal of Share Buyback Program and Automatic Securities Purchase Plan.” This news release is being republished to correct an error in the average daily traded volume in the initial news release. The complete, corrected news release follows: Currency Exchange International, Corp. today announced acceptance by the Toronto Stock Exchange (the “TSX“) of Currency Exchange’s Notice of Intention to renew its normal course issuer bid (the “NCIB“) and Automatic Securities Purchase Plan (the “ASPP”) to purchase for cancellation a maximum amount...

Corrective information regarding the Annual Report 2024 and the Interim Report for H1 2025 following an order from the Danish Business Authority Copenhagen, 26 November 2025 Company Announcement no. 12 Pharma Equity Group A/S (“the Company”) hereby publishes the consequences of a correction to the Company’s Annual Report for 2024 and Interim Report for the first half of 2025. This company announcement is issued following an order from the Danish Business Authority dated 20 November 2025 in case no. 2024-5542. The Authority has ordered the Company to apply an “Expected Credit Loss” (ECL) model in accordance with IFRS 9 for the measurement of the Company’s receivable from Portinho S.A. Publication of formal supplement The Company’s auditor, BDO Statsautoriseret Revisionsaktieselskab, has commenced...

DENVER, Nov. 26, 2025 (GLOBE NEWSWIRE) — Xeriant (OTCQB:XERI) is sharpening its identity as a next-generation technology accelerator with the appointment of Brig. Gen. (Ret.) Blaine D. Holt as president of its newly defined Factor X Research Group, an expanded innovation division designed to function as a modern counterpart to Lockheed Martin’s legendary Skunk Works. Factor X represents Xeriant’s push to unite elite scientific and engineering talent under a single mission: compress development cycles, integrate breakthrough systems across disciplines, and drive disruptive technologies from early discovery into scalable deployment. The group’s mandate spans sectors where Xeriant sees near-term commercialization potential, including aerospace and defense, advanced construction materials, critical infrastructure, and AI-enabled platforms. Xeriant...

EUROCASTLE INVESTMENT LIMITED                                         FOR IMMEDIATE RELEASE  Contact:         Oak Fund Services (Guernsey) Limited Company Administrator Attn: Nicole Barnes Tel: +44 1481 752957 Eurocastle announces Director/PDMR Dealing Notification Guernsey, 26 November 2025 – By reference to its obligations under Article 19 of EU Regulation 596/2014, Eurocastle Investment Limited is making public the following details of dealings in its shares by persons discharging managerial responsibilities and their closely associated persons:Name of PDMR Financial Instrument Nature of Transaction Date and place of Transaction Volume and price of TransactionMr. Jason de Beauvoir Sherwill Ordinary Shares Purchase of shares 24 November 2025 24 November 2025 2,000 shares at EUR 14.9476 1,000 shares at EUR 14.8782ABOUT...

Additional Cash Deployment Reflects Confidence in ZEC’s Role Within Reliance’s Long-Term Treasury Strategy LAKEWOOD, NJ, Nov. 26, 2025 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance”, “we” or the “Company”) today announced that it has deployed additional cash into its Zcash (ZEC) position, as part of its focused Digital Asset Treasury (“DAT”) strategy. This step follows Reliance’s recent consolidation of its digital asset holdings into Zcash and reflects the Company’s current view of ZEC as its primary digital asset exposure within that strategy. Zcash’s architecture, featuring a Bitcoin-based security model enhanced with optional privacy and selective disclosure, continues to distinguish it from other blockchain networks. Its dual-transaction model provides transparency when appropriate while enabling...